Advertisement
Advertisement

TENX

TENX logo

Tenax Therapeutics, Inc.

11.66
USD
Sponsored
+0.01
+0.09%
May 08, 16:00 UTC -4
Closed
exchange

Pre-Market

11.83

+0.17
+1.46%

Tenax Therapeutics, Inc. Profile

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation and implanted glucose sensing. Tenax Therapeutics Inc., formerly known as Oxygen Biotherapeutics, Inc., is based in United States.

Info & Links

CEO

Christopher T. Giordano

Headquarters

101 GLEN LENNOX DRIVE, SUITE 300
CHAPEL HILL, NC 27517, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.tenaxthera.com

Auditor

Cherry Bekaert LLP

Share holders

1,328

Employees

16

Tenax Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

304.92M

Enterprise Value

207.36M

Enterprise Value/EBITDA(ttm)

-3.68

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.44

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-51.83%

Return on Invested Capital(ttm)

-52.46%

Return on Assets(ttm)

-49.51%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-56.39M

Net Income Available to Common(ttm)

-52.60M

Diluted EPS(ttm)

-1.33

Share Statistics

Beta (5Y Monthly)

1.19

52-Week Change

109.34%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.20M

Dividend Yield

0.00%

Float4

16.66M

% Held by Insiders

3.14%

% Held by Institutions

1.67%

Balance Sheet

Total Cash(mrq)

97.56M

Total Cash Per Share(mrq)

5.67

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.56%

Quick Ratio(mrq)

14.56%

Book Value Per Share(mrq)

10.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.91

Free Cash Flow(ytd)

-35.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement